The Female Health Company (AMEX: FHC), the sole manufacturer and marketer of the FC1 and FC2 female condoms, provides an innovative option to women that protects against both sexually transmitted diseases and unintended pregnancy. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People’s Republic of China, South Korea and Japan, while patents are pending for FC2. For further information, visit the Company’s web site at www.femalehealth.com.
- 16 years ago
QualityStocks
The Female Health Company (AMEX: FHC)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Better Choice Company, Inc. (NYSE American: BTTR) Completes Merger with SRx Health, Will Rebrand as SRx Health Solutions Inc.
Better Choice Company (NYSE American: BTTR) announced the closing of its business combination with SRx…
-
Brera Holdings PLC’s (NASDAQ: BREA) S.S. Juve Stabia S.r.l Posts Largest Valuation Percentage Gain; Signals Club’s Growing Competitiveness
Brera Holdings, an Ireland-based, international holding company focused on expanding its global portfolio of men’s…
-
QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Moves Forward to Strengthen the Case for HyBryte(TM)
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”)…